BCL2 and neoplasm: This effect in vivo required Bcl2 silencing, IFN, and natural killer cells as evidenced by rescuing with Bcl2 target mutation via Bcl2 mRNA site cleavage in lung metastases and Bcl2 protein downregulation in tumor cells (57).